Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Blum, Christopher, Steinseifer, Ulrich, Neidlin, Michael
Format: Preprint
Veröffentlicht: 2024
Schlagworte:
Online-Zugang:https://arxiv.org/abs/2407.18757
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866916337383636992
author Blum, Christopher
Steinseifer, Ulrich
Neidlin, Michael
author_facet Blum, Christopher
Steinseifer, Ulrich
Neidlin, Michael
contents Purpose: The purpose of this study is to address the lack of uncertainty quantification in numerical hemolysis models, which are critical for medical device evaluations. Specifically, we aim to incorporate experimental variability into these models using the Markov Chain Monte Carlo (MCMC) method to enhance predictive accuracy and robustness. Methods: We applied the MCMC method to an experimental hemolysis dataset to derive detailed stochastic distributions for the hemolysis Power Law model parameters $C$, $α$ and $β$. These distributions were then propagated through a reduced order model of the FDA benchmark pump to quantify the experimental uncertainty in hemolysis measurements with respect to the predicted pump hemolysis. Results: The MCMC analysis revealed multiple local minima in the sum of squared errors, highlighting the non-uniqueness of traditional Power Law model fitting. The MCMC results showed a constant optimal $C=3.515x10-5$ and log normal distributions of $α$ and $β$ with means of 0.614 and 1.795, respectively. The MCMC model closely matched the mean and variance of experimental data. In comparison, conventional deterministic models are not able to describe experimental variation. Conclusion: Incorporating Uncertainty quantification through MCMC enhances the robustness and predictive accuracy of hemolysis models. This method allows for better comparison of simulated hemolysis outcomes with in-vivo experiments and can integrate additional datasets, potentially setting a new standard in hemolysis modeling.
format Preprint
id arxiv_https___arxiv_org_abs_2407_18757
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Towards Robust Hemolysis Modeling with Uncertainty Quantification: A Universal Approach to Address Experimental Variance
Blum, Christopher
Steinseifer, Ulrich
Neidlin, Michael
Medical Physics
Purpose: The purpose of this study is to address the lack of uncertainty quantification in numerical hemolysis models, which are critical for medical device evaluations. Specifically, we aim to incorporate experimental variability into these models using the Markov Chain Monte Carlo (MCMC) method to enhance predictive accuracy and robustness. Methods: We applied the MCMC method to an experimental hemolysis dataset to derive detailed stochastic distributions for the hemolysis Power Law model parameters $C$, $α$ and $β$. These distributions were then propagated through a reduced order model of the FDA benchmark pump to quantify the experimental uncertainty in hemolysis measurements with respect to the predicted pump hemolysis. Results: The MCMC analysis revealed multiple local minima in the sum of squared errors, highlighting the non-uniqueness of traditional Power Law model fitting. The MCMC results showed a constant optimal $C=3.515x10-5$ and log normal distributions of $α$ and $β$ with means of 0.614 and 1.795, respectively. The MCMC model closely matched the mean and variance of experimental data. In comparison, conventional deterministic models are not able to describe experimental variation. Conclusion: Incorporating Uncertainty quantification through MCMC enhances the robustness and predictive accuracy of hemolysis models. This method allows for better comparison of simulated hemolysis outcomes with in-vivo experiments and can integrate additional datasets, potentially setting a new standard in hemolysis modeling.
title Towards Robust Hemolysis Modeling with Uncertainty Quantification: A Universal Approach to Address Experimental Variance
topic Medical Physics
url https://arxiv.org/abs/2407.18757